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Methylome analysis for spina bifida shows
SOX18 hypomethylation as a risk factor
with evidence for a complex (epi)genetic
interplay to affect neural tube development
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Abstract
Background: Neural tube defects (NTDs) are severe congenital malformations that arise from failure of neurulation
during early embryonic development. The molecular basis underlying most human NTDs still remains largely
unknown. Based on the hypothesis that folic acid prevents NTDs by stimulating methylation reactions, DNA
methylation changes could play a role in NTDs. We performed a methylome analysis for patients with
myelomeningocele (MMC). Using a candidate CpG analysis for HOX genes, a significant association between
HOXB7 hypomethylation and MMC was found.
Methods: In the current study, we analyzed leukocyte methylome data of ten patients with MMC and six controls
using Illumina Methylation Analyzer and WateRmelon R-packages and performed validation studies using larger
MMC and control cohorts with Sequenom EpiTYPER.
Results: The methylome analysis showed 75 CpGs in 45 genes that are significantly differentially methylated in
MMC patients. CpG-specific methylation differences were next replicated for the top six candidate genes ABAT,
CNTNAP1, SLC1A6, SNED1, SOX18, and TEPP but only for the SOX18 locus a significant overall hypomethylation
was observed (P value = 0.0003). Chemically induced DNA demethylation in HEK cells resulted in SOX18
hypomethylation and increased expression. Injection of sox18 mRNA in zebrafish resulted in abnormal neural
tube formation. Quantification of DNA methylation for the SOX18 locus was also determined for five families
where parents had normal methylation values compared to significant lower values for both the MMC as their
non-affected child. SOX18 methylation studies were performed for a MMC patient with a paternally inherited
chromosomal deletion that includes BMP4. The patient showed extreme SOX18 hypomethylation similar to his
healthy mother while his father had normal methylation values.
Conclusions: This is the first genome-wide methylation study in leukocytes for patients with NTDs. We report
SOX18 as a novel MMC risk gene but our findings also suggest that SOX18 hypomethylation must interplay with
environmental and (epi)genetic factors to cause NTDs. Further studies are needed that combine methylome data
with next-generation sequencing approaches to unravel NTD etiology.
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Background
Neural tube defects (NTDs) are severe congenital mal-
formations with a frequency of one to two per 1000
pregnancies [1]. Despite its high prevalence and severe
consequences, the underlying molecular basis of most
human NTDs remains largely unknown. Folic acid sup-
plementation is known to reduce the incidence of
NTDs, though its mode of action for NTD prevention
is poorly understood. The only well-characterized
genetic risk factor for human NTDs is the 677C>T
change in the 5,10-methylene tetrahydrofolate reduc-
tase (MTHFR) gene. This variant is known to lead to
hyperhomocysteinemia and global DNA hypomethylation
[2–4]. This association led to the hypothesis that folic acid
prevents NTDs by stimulating DNA methylation [2, 5].
To investigate whether changes in DNA methylation are
involved in NTDs, different research groups have quanti-
fied global (e.g., via LINE-1 elements) or locus-specific
(e.g., imprinted genes, transposable elements, DNA repair
enzymes) DNA methylation for patients with NTDs using
DNA from diverse types of tissues [5]. Methylation studies
of imprinted genes in post-mortem brain tissue of NTD
patients showed significant hypermethylation of the IGF2
and H19 differentially methylated regions (DMRs) [6, 7].
Other studies focused on the analysis of DNA repair
genes, but only MGMT was found to be slightly hypo-
methylated in brain tissue of NTD patients [8]. Investiga-
tion of DNA methylation of the candidate genes folate
receptor α (FOLR1), proton-coupled folate transporter
(PCFT), and reduced folate carrier 1 (RFC1) genes did not
show significantly differences between patients and con-
trols, though some minor differences were observed
according to RFC1 80G>A genotype [9]. This suggests a
gene-nutrition interaction between folate intake and the
RFC1 genotype in NTD-affected births. The most robust
finding of all DNA methylation studies for NTDs was
found for LINE-1 and global DNA methylation. Lower
levels of LINE-1 and global DNA methylation were
found for NTD patients. The decrease in methylation
was even more pronounced for cranial compared to cau-
dal NTDs [10]. Previously, we performed a genome-wide
DNA methylation study using the HumanMethylation
450K BeadChip (HM450k) and leukocyte DNA from ten
patients with myelomeningocele (MMC) and six unre-
lated healthy controls. We analyzed these data using a
candidate-gene approach for the Homeobox (HOX)
genes [11]. HOX genes play a central role in neural tube
development and are regulated in a spatiotemporal and
collinear manner, partly by epigenetic modifications
[12]. We found evidence that HOXB7 hypomethylation
is a potential risk factor for MMC. Interestingly, a study
by Kok et al. found that DNA methylation of HOXB7 in
particular but also of the majority of the other HOX
genes tend to be increased after folic acid and vitamin
B12 supplementation [13]. A recent meta-analysis in-
vestigated the impact of maternal plasma folate during
pregnancy on DNA methylation in cord blood [14].
They found that multiple developmental processes are
influenced by maternal folate, including neural tube
development.
For this study, we analyzed the data of the genome-
wide DNA methylation study without focusing on can-
didate genes or pathways to discover novel genes with
methylation changes associated to NTDs. The analysis
was performed using Illumina Methylation Analyzer
(IMA) [15] and WateRmelon [16] R-packages. Findings
were confirmed using a locus-specific validation study
with the Sequenom EpiTYPER and in larger MMC and
control cohorts. The most significant overall hypomethy-
lation was found for the SOX18 locus in MMC patients.
Furthermore, SOX18 expression studies were performed
in chemically induced hypomethylated DNA from HEK
cells, and neural tube development was studied in sox18
messenger RNA (mRNA)-injected zebrafish embryos.
Additionally, we quantified SOX18 methylation in five
families that include parents, the MMC patient, and its
non-affected sibling and in one family with a MMC pa-
tient that has a paternally inherited BMP4 deletion.
Results
DNA methylation of LINE elements and folic acid
regulatory genes
Findings of global DNA and LINE-1 hypomethylation
in patients with NTDs [10, 17] suggest that genomic
instability might interfere with neural tube closure.
Analysis of LINE-1 methylation in our HM450k study
showed no overall methylation difference between MMC
patients and controls (mean β value was 77.6 versus
77.7 %; respectively). However, unsupervised hierarchical
clustering analysis grouped almost all MMC patients
separately from the controls, which suggests a similar
DNA methylation pattern (Additional file 1: Figure S1;
Additional file 5: Table S1).
We next analyzed 43 genes involved in the folic acid
and the one carbon metabolism [18], but there were no
significant methylation differences between MMC patients
and controls (Additional file 2: Figure S2; Additional file 5:
Table S2). According to unsupervised hierarchical clus-
tering analysis, samples are clustered irrespective of the
subgroup.
Methylome analysis for gene identification
The analysis of HM450k data showed significant methy-
lation differences for 45 genes (comprising 75 CpG sites)
using selection criteria that include a β value >0.10 and
P value <0.01. Out of these 75 CpG sites, 72 % CpG sites
were associated with hypomethylation for MMC patients
compared to controls (Additional file 5: Table S3).
Rochtus et al. Clinical Epigenetics  (2016) 8:108 Page 2 of 12
Further selection of genes with more than one single
significantly differentially methylated CpG resulted in six
candidate genes ABAT, CNTNAP1, SLC1A6, SNED1,
SOX18, and TEPP (Table 1). Pathway analysis of the 45
genes showed enrichment of fundamental developmental
pathways. The gene ontology classes implicated include
cytoplasm, transcription, neuron projection, synaptic
processes, cell projection, and some minor others (Fig. 1).
Interestingly, our candidate genes seem to act together
through various pathways, as they are often involved in
divergent gene ontology categories (Additional file 5:
Table S4). This pathway analysis favors the hypothesis
that NTDs are the result of a complex multifactorial
combination. Results for the most significant CpGs ac-
cording to only having a P value <0.001 (independent of
the change in β value) are represented in Additional file
5: Table S5. Among these 370 highly significant CpGs,
58 % are hypomethylated in patients with NTDs.
Validation study in larger MMC and control cohorts
A validation study was performed with the Sequenom
EpiTYPER to quantify DNA methylation for loci that
contain the CpGs of the six highest ranked genes. The val-
idation was performed for 83 MMC patients (Additional
file 5: Table S6 and previously described in detail in [11])
and 30 unrelated healthy controls. We found for all six
genes CpG-specific methylation differences between
MMC patients and controls (Fig. 2; left panels, Additional
file 5: Table S6). However, when the total methylation
value for each gene locus was quantified, a significant
change was only detected for the SOX18 locus between
MMC patients and controls (−14 %; 95 % CI (−8 %,
−20 %), P value = 0.0003) (Fig. 2; right panels). For the
other five genes, ABAT, CNTNAP1, SLC1A6, SNED1, and
TEPP, the overall methylation of the studied locus
remained not significant. Global DNA hypomethylation
has been associated with the MTHFR 677C>T variant.
Similar to our previous findings for the HOXB7 locus [11],
we did not find an association between MTHFR 677 CC
versus CT+TT genotype and changes in SOX18 methyla-
tion values (Additional file 3: Figure S3). This suggests
that an intrinsic defect in the folic acid pathway related to
MTHFR activity seems not to be involved.
Chemically induced demethylation versus gene
expression analysis
Demethylation studies were performed in HEK cells
that were treated for 72 h with 5 μM 5-aza-2′-deoxycy-
tidine (AZA). Bisulfite sequencing using primers similar
to the Sequenom EpiTYPER study (Additional file 5:
Table S8) confirmed CpG demethylation for all CpGs
within the top six ranked genes (ABAT, CNTNAP1,
SLC1A6, SNED1, SOX18, and TEPP) after AZA treat-
ment but again with the most pronounced difference
detected for the SOX18 locus (Fig. 3a). Gene expression
was measured for ABAT, CNTNAP1, SLC1A6, SNED1,
SOX18, and TEPP using qRT-PCR, but only TEPP and
SOX18 expression was significantly increased after
AZA treatment (Fig. 3b).
Table 1 Top six differentially methylated genes investigated by HM450k and selected for validation with Sequenom EpiTYPER
Gene Illumina ID Chr Mapinfo WateRmelon IMA R-package Gene
groupP value β diff P value β diff
ABAT Chr16p13 cg01881182 16 8806531 0.0017 −0.20 0.0047 −0.15 5′ UTR
cg16586594 16 8806569 0.0005 −0.18 0.0005 −0.19 5′ UTR
cg08834902 16 8806690 0.0047 −0.23 0.0047 −0.16 5′ UTR
SLC1A6 Chr19p13 cg12695707 19 15121333 0.0002 −0.27 0.0005 −0.16 TSS1500
cg09470638 19 15121509 0.0010 −0.25 0.0048 −0.14 TSS200
cg02489552 19 15121531 0.0002 −0.14 0.0002 −0.21 TSS200
SOX18 Chr20q13 cg02231404 20 62679635 0.0010 −0.20 0.0010 −0.21 Body
cg22138735 20 62679713 0.0005 −0.17 0.0005 −0.17 Body
TEPP Chr16q21 cg04370442 16 58019866 0.0047 −0.15 0.0075 −0.16 Body
cg12499872 16 58019893 0.0005 −0.31 0.0005 −0.15 Body
CNTNAP1 Chr17q21 cg16308533 17 40838983 0.0005 −0.17 0.0010 −0.19 Body
cg11629889 17 40839022 0.0002 −0.14 0.0010 −0.16 Body
SNED1 Chr2q37 cg23491743 2 241989271 0.0017 −0.16 0.0030 −0.17 Body
cg25241559 2 241989379 0.0005 −0.15 0.0005 −0.17 Body
Selection is performed after analysis with two pipelines and application of three selection criteria: (i) absolute β value difference >0.10; (ii) P value <0.05; and (iii)
presence of multiple CpGs per locus. Nucleotide positions accord to NCBI build 37/hg19. Gene group is defined relative to the nearest open reading frame: within
1500 (TSS1500) or 200 bp (TSS200) of a transcription start site, in the 5′ untranslated region (5′ UTR), the first exon of a transcript (exon), in the body of gene
(body) or the 3′ UTR (3′ UTR). These six genes were selected for the validation study using Sequenom EpiTYPER
β diff β difference, Chr chromosome, Illumina ID identification according to HM450k, MMC myelomeningocele
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Gene expression studies in zebrafish
Functional genetic studies were performed in zebrafish
to study alterations of sox18 and abat expression during
embryogenesis and neural tube formation. Both genes
are highly conserved between humans and zebrafish
(68 % for sox18 and 70 % for abat). Embryos injected
with abat mRNA developed abnormal neural tube struc-
tures in about 50 % of the embryos though they were
only mildly malformed (Fig. 4a). Injection of sox18
mRNA resulted in a developmental delay with severe
malformations in 74 % of the embryos that clearly show
abnormal neural tube formation (Fig. 4b). Folic acid
could not rescue these neural tube deformities (Fig. 4c).
SOX18 methylation studies in five MMC patients and their
non-affected siblings and parents
To study the inheritance of the SOX18 methylation
changes, we quantified SOX18 methylation for five
MMC patients and their non-affected siblings and parents
with the Sequenom EpiTYPER (Fig. 5a). Interestingly, not
only the MMC patients but also their non-affected
healthy siblings presented with similar levels of SOX18
hypomethylation whereas their parents had methylation
values comparable to these of the unrelated control cohort
(Fig. 5a). There were no significant DNA methylation
differences between the five MMC patients, their siblings,
and the overall MMC cohort. Also, the quantification of
DNA methylation for the separate CpGs revealed higher
methylation values for the parents compared to the MMC
patient and its healthy sibling for all CpGs (Fig. 5b). These
data would imply that SOX18 hypomethylation is not
sufficient to cause a NTD.
SOX18 methylation studies in the parents of a MMC
patient with a paternally inherited BMP4 deletion
To investigate the influence of an underlying genetic fac-
tor, SOX18 DNA methylation was quantified in a boy with
lumbosacral MMC and his parents. The boy has pater-
nally inherited microdeletions that comprise 14q22.1q22.2
and 2p11.2. 14q22.1q22.2 covering the genes FERMT2,
DDHD1, BMP4, DKN3, and CNIH (Additional file 4:
Figure S4) while the other deletion in the 2p11.2 region is
located in a gene desert region. The father has postaxial
polydactyly, severe myopia, and pro-optosis but no spina
bifida. His clinical phenotype is compatible with a BMP4
deletion syndrome. Interestingly, BMP4 is one of the 45
genes that showed DNA methylation changes in our
HM450k analysis (Additional file 5: Table S3) and is also
present in the functional enrichment network very closely
connected to SOX18 (Fig. 1a). The BMP4 deletion patient
Fig. 1 Gene ontology enrichment map based on top differentially methylated genes in MMC patients. The map displays three clusters of functionally
related gene-sets in MMC patients versus controls (a–c). Gray nodes represent GO classes and the size of each node is correlated with its significance
(adjusted P value). Green and red nodes represent hypomethylated and hypermethylated genes, respectively. The intensity of the color is correlated
with β difference
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Fig. 2 (See legend on next page.)
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and also his mother presented significantly lower methyla-
tion values compared to the father and the group of unre-
lated healthy controls (Fig. 5a, b).
Discussion
Current research supports the hypothesis that abnor-
mal DNA methylation contributes to NTDs [5, 19].
However, rather than DNA hypomethylation of individ-
ual candidate loci, a complex combination of environ-
mental and (epi)genetic factors are likely causative for
NTDs [20, 21]. Analysis of HM450k methylation data
for ten MMC patients and six unrelated healthy controls
showed no statistically significant difference in global
DNA methylation as determined via the LINE-1 and
LINE-2 methylation. However, unsupervised hierarchical
clustering showed similar global DNA methylation pat-
terns for the MMC patients. Genes implicated in the folic
acid metabolism were not significantly differentially meth-
ylated between patients and controls. To investigate which
genes are significantly differentially methylated in patients
with NTDs, we next analyzed the HM450k data without
prioritizing for candidate genes. As the two Infinium as-
says of the HM450k generate two different types of data
[22], we used two analysis pipelines with a different cor-
rection and normalization method (WateRmelon and
IMA). We identified significant hypomethylation for the
genes ABAT, CNTNAP1, SLC1A6, SNED1, SOX18, and
TEPP. Further validation by Sequenom EpiTYPER con-
firmed CpG-specific DNA hypomethylation for these
genes. However, only the SOX18 locus showed highly
significant overall hypomethylation for MMC patients. Re-
cessive and dominant mutations in SOX18 in humans are
known to cause hypotrichosis-lymphedema-telangiectasia
syndrome with a combination of hair and cardiovascular
(See figure on previous page.)
Fig. 2 Validation of the top six differentially methylated genes by Sequenom EpiTYPER in MMC patients versus controls. Left: methylation pattern
for each CpG unit within the amplicons. Multiple t test was performed for each CpG. *P value <0.05. Right: boxplot representing methylation
pattern with box = 25th and 75th percentiles; bars =min and max values. The mean methylation level of each group is shown above the plot.
The validation study is performed for 83 MMC patients and 30 controls. *CpGs were first identified by HM450k
Fig. 3 Demethylation studies and gene expression analysis. Demethylation studies were performed using 5 μM 5-aza-2′-deoxycytidine in HEK cell
line. a Sanger sequencing showing demethylation of SOX18 after 5-aza-2′-deoxycytidine treatment. The CpGs from the SOX18 amplicon are annotated
below the sequence. b Gene expression analysis of top six genes using qRT-PCR. Standard standard culture conditions, AZA 5-aza-2′-deoxycytidine.
*P value <0.05, ***P value <0.001
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anomalies, including symptoms of lymphatic dysfunction
[23]. Most studies available to date have focused on the
role of SOX18 depletion or loss of function mutants while
our study points to a potential role of SOX18 hypome-
thylation leading to increased SOX18 expression. Inter-
estingly, a recent study of Petrovic et al. suggests that
Hedgehog signalling up-regulates SOX18 expression,
which promotes migration [24]. Hedgehog signalling is
known to play an important role in neural tube develop-
ment [24, 25]. Evidence for a role for SOX18 in neural
tube formation is also supported by our zebrafish studies
that showed strongly malformed tails with abnormal
neural tube development in embryos with high levels of
sox18 after injection of its mRNA.
As periconceptional folate is important for NTD pre-
vention, we compared our findings with a large dataset
that examined the association between maternal plasma
folate during pregnancy and genome-wide DNA methy-
lation in newborn cord blood [14]. Interestingly, one of
the top differentially methylated CpGs of this study
(cg12695707 within the SLC1A6 gene locus) was also
detected as a hypomethylated CpG in our study (Table 1).
Therefore, SLC1A6 seems to be sensitive to maternal
plasma folate in both healthy controls as in MMC pa-
tients. In addition, multiple developmental processes seem
to be influenced by maternal folate, including neural tube
development. Recently, we described the importance of
HOX gene methylation in neurulation [11], which is also
influenced by maternal plasma folate [13]. In addition, we
checked if our candidate genes are also represented in
another large-scale meta-analysis that investigated the in-
fluence of maternal smoking on DNA methylation in new-
borns [26]. Five of our 75 candidate loci with abnormal
methylation being BMP4, ENAH, GALNT2, and NRP2
and one CpG in a locus without an annotated gene seem
to be highly significantly influenced by maternal smoking.
Bone morphogenetic protein 4 (BMP4) is of special inter-
est as it is involved in craniofacial development and an
important candidate gene for cleft palate defects [27].
However, BMP4 has not yet been implicated directly in
lumbosacral MMC.
In addition to dietary and environmental factors, DNA
sequence variability influences DNA methylation. The in-
fluence of DNA sequence variability on DNA methylation
is estimated to differ between 22 and 80 % [28]. In order
to investigate how genetic factors might influence DNA
methylation, we first genotyped the MTHFR 677C>T vari-
ant as this variant is known to lead to hyperhomocysteine-
mia and global DNA hypomethylation especially under
low folate conditions [29]. We did not find an additive
effect of the MTHFR variant on SOX18 methylation. To
investigate whether candidate genes from literature might
be differentially methylated, we compared the findings of
our top 45 significantly differentially methylated genes
with the gene list from a recent NTD wiki database that
provides an online up-to-date list of genes implicated in
neural tube closure (http://ntdwiki.wikispaces.com). Only
one of our top genes, ENAH, was present in the candidate
gene list. However, the interplay between genetics and epi-
genetics in driving a disease phenotype is not well under-
stood and is completely unknown for NTD etiology. As
we hypothesized that there may be a maternal factor that
contributes to a disturbed DNA methylation cycle, we
performed SOX18 methylation studies for five families in-
cluding the MMC patient and their non-affected parents
Fig. 4 Phenotype analysis of gene overexpression in zebrafish embryos.
Pax2a staining after microinjection of abat mRNA (a) and sox18 mRNA
(b). Wild-type (WT) zebrafish show expression in the hindbrain,
hindbrain-midbrain boundary, neural tube, mesoderm, optic stalk, otic
vesicle, and pronephric duct. Spinal cord malformation is indicated with
an arrow. c Phenotype analysis after pax2a staining at 24 hpf resulted in
respectively 50 and 74 % embryos with an affected phenotype
after abat and sox18 overexpression. Folic acid supplementation
after gene overexpression did not significantly influence the
phenotype. ***P value <0.001
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and sibling. Both parents had methylation levels compar-
able to these of the control cohort while the MMC
patients and their healthy siblings had significantly lower
SOX18 methylation. These findings suggest that there
might be a parental genetic or epigenetic contribution that
leads to a disturbed one-carbon metabolism and methyla-
tion pattern. In addition, we report here the first MMC
case with a combined genetic and DNA methylation
defect involving a paternally inherited chromosomal de-
letion that includes BMP4 and a maternally inherited
defect in SOX18 methylation. The MMC child, born
from Caucasian non-related parents, was diagnosed
with a lumbosacral NTD and carries a paternally inher-
ited 14q22.1-2 deletion that involves FERMT2, DDHD1,
BMP4, DKN3, and CNIH. BMP4 deletions have been
associated with variable defects of the eyes, palate, limbs,
and brain and with developmental and growth delay but
not with NTDs [30, 31]. Mutations in DDHD1 are found
in patients with hereditary spastic paraplegia [32]; CDKN3
is linked with different cancers while for FERMT2 and
CNIH, no human diseases have been described. The father
with the same chromosomal deletion has postaxial
polydactyly, severe myopia, and pro-optosis but no NTD.
Interestingly, methylation studies in the parents and
patient showed pronounced hypomethylation of SOX18 in
the mother and patient. Though further biological studies
are needed to support any functional interplay between
BMP4 and SOX18, this pedigree illustrates the inheritance
of a genetic deletion that could cause a NTD in combin-
ation with DNA hypomethylation. It is worth to notice
that both SOX18 [24, 33, 34] and BMP4 [35, 36] have been
described as regulators of angiogenesis and this could ex-
plain an old concept that there might be a vascular basis
for NTDs [37]. The vascular hypothesis states that NTDs
result from a disturbance in the timely development of the
vasculature. A constant nutrition supply is essential for
normal embryonic development. The transition from an
avascular to a vascular organism is normally accomplished
during the fourth postconceptional week. The neural sys-
tem has a very prolific growth during the prevascular stage
and is therefore the first to outgrow its nutrient supply. As
both SOX18 and BMP4 are implicated in the establish-
ment of a vascular network, conjunct dysfunction might
disturb nutrient supply in early development and lead to
NTDs [33, 34].
An important shortcoming of our study is the fact
that we only had access to leukocyte DNA for assessment
of methylation. We do not know whether differential
Fig. 5 SOX18 methylation for the family study and the BMP4 study by Sequenom EpiTYPER. a Mean methylation and standard deviation of SOX18
methylation for the family study and the BMP4 study. The mean methylation level of each group is shown above the plot. *P value <0.05, **P value
<0.01, ***P value <0.001, ****P value <0.0001. b Methylation pattern for each CpG unit within the SOX18 amplicon for the family study. Multiple t test
was performed for each CpG. *P value <0.05. c Methylation pattern for each CpG unit within the SOX18 amplicon for the BMP4 study. Multiple t test
was performed for each CpG. *P value <0.05. The family study consists of MMC patients, their unaffected siblings, and their parents (n = 5 for each
group). The BMP4 study describes the family of a patient with a BMP4 deletion. The father is carrier of the BMP4 deletion
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methylation of the same gene set would be observed in
brain or spinal cord tissue of MMC patients. But concord-
ant methylation alterations in brain and blood suggest that
blood methylation might be representative for brain
methylation [38–42]. Hannon et al. generated an online
tool which allows to investigate the correlation of DNA
methylation of blood and four brain regions for all probes
present on the HM450k [43]. Comparison for SOX18
methylation shows a good correlation between variation
in blood and the cortical regions of the brain. Moreover, it
is known that DNA methylation in blood is significantly
more variable than DNA methylation in brain tissues [39].
Horvath et al. [41] and Farré et al. [39] identified a DNA
methylation signature of age that is not related to cell type
composition and that does not require a correction for
cellular heterogeneity. This is an interesting finding, as
until now there was still no clear evidence that DNA
methylation marks of different cell types respond in a
similar way to environmental influences. The sample
size of our genome-wide study was small, but the re-
producibility of significant hypomethylation of the top
CpGs in a much larger cohort suggests that the applica-
tion of two pipelines to analyze the HM450k dataset
was a good strategy.
Conclusions
This is the first study that investigates genome-wide
DNA methylation in leukocytes in patients with NTDs.
We report SOX18 as novel risk gene for NTDs but our
findings also suggest that SOX18 hypomethylation and
increased expression must interplay with other environ-
mental and (epi)genetic factors that are causative for
NTDs. Therefore, further studies should focus on a gene
discovery design for MMC that includes both DNA
methylation and next-generation sequencing approaches.
It is possible that gene variants in combination with
changes in methylation are more prone to result in a
multifactorial disease as spina bifida.
Methods
Description of MMC patients, related healthy siblings, and
unrelated healthy controls
A total of 85 MMC patients, 12 healthy related siblings,
and 30 age- and gender-matched non-related healthy
control subjects enrolled in this study. The MMC patients
are followed at the Pediatric Neurology Department of the
University Hospital Leuven (all <18 years). Detailed clin-
ical and general characteristics for all these subjects are re-
ported in Additional file 5: Table S6 and have been
previously reported in Table 1 of [11]. As sensory and
motor functions at and below the level of the spinal cord
defect are impaired, paralysis and bowel and bladder dys-
function are present in most of the patients. Folic acid
supplementation was recommended, but red blood cell
folate was not measured during pregnancy. For the family
study, we included the parents of five sibling pairs (pairs 5,
27, 29, 41, and 60 from [11]).
Description of a case of Caucasian boy with BMP4
deletion
The male patient was born at full term to a G2P1
Caucasian mother by a lower segment caesarean sec-
tion after an uncomplicated pregnancy with normal
prenatal ultrasounds. At birth, he presented an open
lumbosacral myelomeningocoele and bilateral talipes
equinovarus. The anterior fontanelle was full and bul-
ging. Bilateral lower limb weakness was evident, and
initially, he did not have neurogenic bladder or bowel
dysfunction. Cranial ultrasound revealed hydrocephaly
and Arnold-Chiari II malformation. External ventricu-
loperitoneal drainage and surgical repair of the spinal
defect were performed at the day of birth. Renal ultra-
sound showed a multicystic dysplastic kidney on the
right side.
Comparative genomic hybridization using an 180k
oligo array platform (180K Cytosure ISCA v2, OGT,
Oxford, UK) showed a 1.665 kb deletion on chromo-
some 14q22.1q22.2 (14:53,267 987-54,933 219; NCBI/
hg19, February 2009) and a microdeletion on chromo-
some 2p11.2 (2:83,380 184-83,915 440; NCBI/hg19,
February 2009). The deleted region on chromosome 14
spans the genes FERMT2, DDHD1, BMP4, DKN3, and
CNIH (Additional file 4: Figure S4); the microdeletion
on chromosome 2 does not cover any known gene. The
father of the patient has postaxial polydactyly, severe
myopia, and pro-optosis and carries both deletions.
The mother of the patient has a 45X/46XX mosaicism.
She consumed periconceptional synthetic folic acid
supplementation. The DECIPHER ID of the patient is
288171 (https://decipher.sanger.ac.uk).
MTHRF 677C>T genotyping
Leukocyte DNA from MMC patients, related healthy
siblings, and unrelated healthy controls was screened for
the presence of the MTHFR 677C>T variant by PCR and
restriction digestion as described [44]. The MTHFR
genotype of the 85 MMC patients and 12 unaffected
siblings is previously reported in [11]. Genotyping for
the 10 parents of the family study revealed six parents
(3M/3F) with a CT genotype and four parents (2M/2F)
with a CC genotype.
Genome-wide DNA methylation analysis using the
HM450K
Leukocyte DNA (1 μg) was subjected to bisulfite treat-
ment using the EZ DNA methylation kit using manu-
facturers standard protocol (Zymo Research, Irvine CA,
USA). Subsequently, genome-wide DNA methylation
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was assessed using Illumina Infinium HumanMethylation
450K BeadChip (Illumina, Inc., California, USA). The
HM450k experiment and data preprocessing were per-
formed as described previously [11]. The analysis was con-
ducted using both the Illumina Methylation Analyzer
(IMA) package implicated in the open-source statistical
environment R and the WateRmelon R-package [16]. The
following three filters were applied on the data for the two
pipelines to identify the most significant differentially
methylated regions between MMC patients and controls:
(i) absolute β value difference >0.10; (ii) P value <0.01; and
(iii) presence of multiple CpGs per locus. The data dis-
cussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus [45] and are accessible through
GEO Series accession number GSE81846.
DNA methylation of LINE elements and folic acid
regulatory genes
We analyzed the methylation values for all LINE-1 and
LINE-2 probes from the HM450k study. About 20158
CpG probes correspond to 1498690 LINE-1 and LINE-
2 elements (Additional file 5: Table S1). We next ana-
lyzed 43 genes (including 698 CpG probes) involved in
the folic acid and the one carbon metabolism [18]
(Additional file 5: Table S2). Cluster analysis was per-
formed within the R statistical environment.
Functional enrichment analysis
Based on the results from the genome-wide DNA
methylation analysis, a list of CpGs corresponding to
differentially methylated CpG sites was generated and
tested for enrichment of known gene ontology path-
ways. This is performed by means of a hypergeometric
test and an FDR-based multiple testing correction of
the obtained P values. The cut-off threshold was set at
P < 0.001. The enrichment analysis was visualized using
the open-source plugin Enrichment Map in Cytoscape
3.2.1.
Methylation of CpGs for six genes using the Sequenom
EpiTYPER
Leukocyte DNA (1 μg) was subjected to bisulfite treat-
ment using the MethylDetector™ bisulfite modification
kit (Active Motif, Carlsbad CA, USA). Subsequently,
DNA methylation analysis of the top six differentially
methylated genes was analyzed by Sequenom EpiTYPER
(Sequenom, San Diego, CA, USA) as we described in
previous research [11, 46, 47]. The primers are described
in (Additional file 5: Table S8). Statistical analyses to
quantify DNA methylation differences were performed
using the Prism 6 software (GraphPad Software Inc., San
Diego, CA, USA). Not all DNA methylation values are
normally distributed (D’Agostino and Pearson normality
test). A two-tailed t test with Welch’s correction was
used to assess differences in mean DNA methylation
levels between cohorts for the amplicons considered as
methylation average and for each CpG unit within this
amplicon separately. Detailed characteristics of the ampli-
con positions in UCSC genome browser can be found in
the supplementary folder named “UCSC.”
Gene overexpression in zebrafish
Wild-type AB zebrafish strains were maintained accord-
ing to standard protocols [48]. Embryos were produced
by natural mating and collected and fixed at different
stages based on standard morphological criteria [49].
Zebrafish embryos were injected with abat and sox18
mRNA. The production of mRNA was performed as
previously reported [11]. Details of transcripts and
primers are described in Additional file 5: Table S9. Off-
target effects were assessed by injecting with a standard
control MO against beta-globin (5′-CCT CTT ACC
TCA GTT ACA ATT TAT A 3′). All injected embryos
were life-screened at 24 h post-fertilization (hpf ) using a
Zeiss Lumar V12 (Carl Zeiss Microscopy, Thornwood,
NY, USA) and images were captured with a Leica
DFC310 FX digital color camera (Leica Microsystems,
Wetzlar, Germany). Experiments were performed in trip-
licate. We also investigated if addition of 0.1 mM folic
acid to the egg water would rescue the phenotype [50].
Ethical approval was obtained for these studies.
Pax2a whole mount in situ hybridization
Whole mount in situ hybridization (WISH) for the paired
box gene 2a (pax2a) was performed with digoxigenin-
labeled antisense riboprobes as previously described
[11, 51]. The influence of abat and sox18 mRNA injec-
tion on spinal cord and notochord formation was stud-
ied using standard morphological criteria [49]. WISH
experiments were performed in duplicate.
Gene expression analysis in HEK293 cells
The human embryonic kidney (HEK) cell line were
cultured under standard conditions or pretreated for
72 h with 5 μM 5-aza-2′-deoxycytidine (Sigma Aldrich,
Belgium) for demethylation studies. All cells were
maintained at 37 °C in a humidified environment with
5 % CO2.
Leukocyte DNA (1 μg) was extracted and subjected to
bisulfite treatment using the MethylDetectorTM bisulfite
modification kit (Active Motif, Carlsbad CA, USA) as we
described [46, 47]. The primers from the validation study
were used for PCR amplification (Additional file 5: Table
S8). Subsequently, Sanger sequencing was performed and
the methylation ratios were compared before and after 5-
aza-2′-deoxycytidine treatment.
Total RNA was extracted from cells using TRIzol
(Invitrogen, Ghent, Belgium) reagent, according to the
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manufacturer’s protocol. cDNA was synthesized using re-
verse transcriptase (Invitrogen, Ghent, Belgium). Human
gene expression was measured using Sybr Green PCR.
qRT-PCR reactions were analyzed using an ABI 7000 real-
time PCR machine (Life Technologies). Gene expression
was quantified via the ΔΔCt method [52] and normalized
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
gene expression. Primer sequences are listed in Additional
file 5: Table S10.
Additional files
Additional file 1: Figure S1. Whole genome methylation in MMC
patients versus controls. Unsupervised hierarchical clustering analysis of
the subgroups. Methylation values for LINE-1 and LINE-2 repetitive elements
are extracted from data obtained with the HM450k. Heatmaps represent
3575 randomly selected CpGs (1 % total CpGs). Green and red represent 0
and 1 methylation, respectively. MMC: myelomeningocele. (TIF 10684 kb)
Additional file 2: Figure S2. Heatmap showing methylation of genes
involved in the folate and one carbon metabolism in MMC patients.
Methylation values of the genes are extracted from data obtained with
the HM450k. Green and red represent 0 and 1 methylation, respectively.
MMC: myelomeningocele. (TIF 12951 kb)
Additional file 3: Figure S3. Mean methylation of SOX18 for MMC
patients and controls according to MTHFR 677 C>T genotype by
Sequenom EpiTYPER. Boxplot representing the methylation pattern of
MMC patients and controls divided according to MTHFR 677 C>T
genotype with box = 25th and 75th percentiles; bars = min and max
values. The mean methylation level of each group is shown above the
plot. (TIFF 337 kb)
Additional file 4: Figure S4. Genetic deletion on Chr 14q22 of
Caucasian boy with lumbosacral myelomeningocele. Bar indicates
1.665-kb deletion on chromosome 14q22.1q22.2 (53,267,987-54,933,219)
encompassing the genes FERMT2, DDHD1, BMP4, DKN3, and CNIH.
Nucleotide positions accord to NCBI build 37/hg19. (PDF 9 kb)
Additional file 5: Table S1–S10. (XLSX 1175 kb)
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